List of insiders holdings for Purple Biotech Ltd.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Efron Gil Chief Executive Officer | 2026-03-31 07:48:40 | 34,500,000 0 | 34,500,000 | Form 3 |
| 2 | Schickler Michael Head of Clinical & Reg Affairs | 2026-03-30 16:10:12 | 18,305,472 0 | 18,305,472 | Form 3 |
| 3 | Lankry Shai S Chief Financial Officer | 2026-03-30 17:30:39 | 10,100,000 0 | 10,100,000 | Form 3/A |
| 4 | Rock Simcha Director | 2026-04-17 12:02:01 | 6,157,690 0 | 6,157,690 | Form 3 |
| 5 | Gagnon Robert E. Director | 2026-03-18 18:06:33 | 6,125,000 0 | 6,125,000 | Form 3 |
| 6 | Zilberberg Suzana Director | 2026-04-07 14:56:13 | 6,125,000 0 | 6,125,000 | Form 3 |
| 7 | Agmon Ido Director | 2026-04-06 16:48:48 | 6,043,860 0 | 6,043,860 | Form 3 |